Skip to main content

Table 6 Skeletal and dental treatment effects in the Mentoplate group

From: Early Class III treatment with Hybrid-Hyrax -Facemask in comparison to Hybrid-Hyrax-Mentoplate – skeletal and dental outcomes

Variables

Mentoplate T0

Mentoplate T1

p values

CI 95%

 

SNA°

79.23 ± 3.08

81.47 ± 3.15

0.000*

1.49

2.97

SNB°

80.09 ± 3.05

79.79 ± 3.20

0.070

− 0.42

0.97

ANB°

− 0.86 ± 1.83

1.68 ± 1.55

0.000*

2.20

3.20

WITS mm

− 5.83 ± 1.35

− 1.69 ± 1.32

0.000*

3.74

5.05

ATV mm

59.42 ± 4.97

62.09 ± 5.03

0.000*

1.90

3.44

BTV mm

58.24 ± 7.04

58.50 ± 7.24

0.973

− 0.91

0.88

ABTV mm

1.18 ± 2.88

3.59 ± 2.91

0.000*

2.16

3.17

ML-NL°

27.87 ± 6.18

27.97 ± 6.05

0.869

− 1.26

1.07

ML-NSL°

34.95 ± 6.94

34.40 ± 6.87

0.055

− 0.01

1.11

NSL-NL°

7.08 ± 3.74

6.44 ± 3.56

0.229

− 0.44

1.73

AR-GO-ME°

128.10 ± 4.99

125.14 ± 8.36

0.000*

− 3.96

− 1.94

MOK-A mm

26.43 ± 1.93

26.32 ± 1.86

0.054

0.00

0.22

U1-PP°

110.36 ± 6.79

110.78 ± 5.12

0.752

− 3.22

2.37

L1-ML°

86.52 ± 6.93

85.97 ± 6.22

0.556

− 1.41

2.52

  1. *significant at p < 0.05